Clinical and biological effects of low doses of (3 amino‐1 hydroxypropylidene)‐1,1‐bisphosphonate (APD) in Paget's disease of bone
- 1 February 1982
- journal article
- research article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 12 (1), 29-35
- https://doi.org/10.1111/j.1365-2362.1982.tb00936.x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Biochemical and clinical responses to dichloromethylene diphosphonate (cl2mdp) in paget's disease of boneArthritis & Rheumatism, 1980
- EFFECT OF DICHLOROMETHYLENE DIPHOSPHONATE IN PAGET'S DISEASE OF BONE AND IN HYPERCALCÆMIA DUE TO PRIMARY HYPERPARATHYROIDISM OR MALIGNANT DISEASEThe Lancet, 1980
- EFFECTS OF DISODIUM DICHLOROMETHYLENE DIPHOSPHONATE ON PAGET'S DISEASE OF BONEThe Lancet, 1979
- The comparative effects of dichloromethylene diphosphonate (Cl2MDP) and ethane-1-hydroxy-1,1-diphosphonate (EHDP) on growth and modeling of the rat tibiaCalcified Tissue International, 1977
- Is Paget's disease of bone a viral infection?Calcified Tissue International, 1976
- Human Calcitonin Radioimmunoassay in Normal and Pathological Conditions*European Journal of Clinical Investigation, 1974
- Intestinal absorption of disodium ethane-1-hydroxy-1,1-diphosphonate (disodium etidronate) using a deconvolution techniqueToxicology and Applied Pharmacology, 1973
- DIPHOSPHONATES AND PAGET'S DISEASE OF BONEThe Lancet, 1971
- RELATION BETWEEN SERUM AND URINARY CALCIUM WITH PARTICULAR REFERENCE TO PARATHYROID ACTIVITYThe Lancet, 1969
- A semi-automated determination of phospholipidsClinica Chimica Acta; International Journal of Clinical Chemistry, 1966